All entries for: Eikon Therapeutics, Inc.

May 11, 2026

Eikon Therapeutics, Inc.

Negative Outlook

Millbrae, CA
201-500 employees

In any event, the IRA is likely to have a significant impact on the pharmaceutical industry and may reduce the prices we can charge, and the reimbursement we can receive, for our products, among other effects.

Disease Area: Oncology
Drug Type: Small Molecule
March 30, 2026

Eikon Therapeutics, Inc.

Neutral Outlook

Millbrae, CA
201-500 employees

The effects of the IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Oncology
Drug Type: Small Molecule
Scroll to Top